| Literature DB >> 31743627 |
Allison Kratka1, Peter A Ubel2, Karen Scherr3, Benjamin Murray4, Nir Eyal5, Christine Kirby6, Madelaine N Katz7, Lisa Holtzman8, Kathryn Pollak9, Kenneth Freedburg10, Jennifer Blumenthal-Barby11.
Abstract
Despite doing well on antiretroviral therapy, many people living with HIV have expressed a willingness to accept substantial risks for an HIV cure. To date, few studies have assessed the specific quantitative maximal risk that future participants might take; probed whether, according to future participants, the risk can be offset by the benefits; and examined whether taking substantial risk is a reasonable decision. In this qualitative study, we interviewed 22 people living with HIV and used standard gamble methodology to assess the maximum chance of death a person would risk for an HIV cure. We probed participants' reasoning behind their risk-taking responses. Conventional inductive content analysis was used to categorize key themes regarding decision-making. We found that some people would be willing to risk even death for an HIV cure, and some of their reasons were plausible and went far beyond the health-related utility of an HIV cure. We contend that people's expressed willingness to take substantial risk for an HIV cure should not be dismissed out of hand.Entities:
Keywords: HIV; HIV cure trials; human research ethics; research benefits; research risks
Mesh:
Year: 2019 PMID: 31743627 PMCID: PMC7391483 DOI: 10.1002/eahr.500035
Source DB: PubMed Journal: Ethics Hum Res ISSN: 2578-2355